Soleno Therapeutics Inc (SLNO)
Operating Income Growth
142.14%
TTM · Period ending:
SLNO Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported142.14%period ending
Latest reported142.14%period ending
SLNO TTM Operating Income YoY % (-508.80% → 142.14%)
Year-over-year change
High-resolution chart · PNG
SLNO operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 142.1374% | |
| 105.5194% | |
| 36.6042% | |
| -169.8611% | |
| -269.3953% | |
| -349.5312% | |
| -325.668% | |
| -145.3537% | |
| -108.1349% | |
| -69.6274% | |
| -51.8451% | |
| -21.3851% | |
| 3.7378% | |
| -84.602% | |
| -19.8987% | |
| -34.3572% | |
| -57.6662% | |
| 25.4386% | |
| -9.1543% | |
| -19.1125% | |
| -91.4111% | |
| 24.8495% | |
| 17.7511% | |
| 17.3088% | |
| 40.9896% | |
| -64.9255% | |
| -26.7811% | |
| -21.9113% | |
| -8.4448% | |
| -7.4591% | |
| -44.2851% | |
| -30.5661% | |
| -26.0982% | |
| 2.2175% | |
| 21.8606% | |
| 21.4239% | |
| 17.43% | |
| -11.9276% | |
| -34.8806% | |
| -66.723% | |
| -102.8006% | |
| -135.6441% | |
| -170.9859% | |
| -143.7378% | |
| -102.2% | |
| -508.7983% |